Taizhou Mabtech Pharmaceutical Co.,ltd

This Phase 1 study compares a new biosimilar drug, CMAB015, to the approved psoriasis treatment Cosentyx (secukinumab). The trial involves 114 healthy Chinese men who receive a single injection. Researchers will measure how the drug moves through the body, its safety, and whether…

This study tests a new drug (omalizumab α) against the approved drug Xolair for people with chronic hives that don't get better with antihistamines. About 392 adults aged 15 to 75 will receive either the new drug or Xolair to see how well it reduces itching and hives over 12 week…

This study checks whether a new way of making the drug EnliTuo® works just like the old way. It involves 86 healthy male volunteers who get a single dose of either the new or old version. Researchers measure how the drug moves through the body, its safety, and whether it triggers…